drugset / Trial / NCT02939794
The Effect of Ferric Carboxymaltose on Hemoglobin and Blood Transfusion in Cardiac Surgery
Phase 4
Unknown
200 enrolled
Rambam Health Care Campus
Carmel Medical Center · collabThe Baruch Padeh Medical Center, Poriya · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Anemia after cardiac surgery is a vast phenomena. More than 70% of the patients who under went surgery represented with hemoglobin less than 8 mg/dl (the cutoff for blood transfusion) and more than 80% of the patients receives at least one unit of red blood cell transfusion. There were number of attempts to prevent the postoperative anemia by giving erythropoietin, Iron per os and intra venus iron. non of the above have shown increase in Hemoglobin after the cardiac surgery.
Timeline
- Start
- 2016-11
- Primary completion
- 2018-08
- Completion
- 2019-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ferric carboxymaltose | Other / unclassified | 1000 mg | Intravenous |